Navigation Links
AMN Healthcare Announces First Quarter 2009 Results
Date:5/7/2009

capital structure to support our business; our ability to meet our financial covenants, which if not met, could adversely affect our liquidity; the loss of key officers and management personnel that could adversely affect our ability to remain competitive; the effect of recognition by us of an impairment to goodwill; our ability to maintain and enhance the brand identities we have developed, at reasonable costs; and the effect of adjustments by us to accruals for self-insured retentions. Other factors that could cause actual results to differ from those implied by the forward-looking statements contained in this earnings release are set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2008 and its other quarterly and periodic reports filed with the SEC. These statements reflect the Company's current beliefs and are based upon information currently available to it. Be advised that developments subsequent to this earnings release are likely to cause these statements to become outdated with the passage of time. The Company does not intend, however, to update the guidance provided today prior to its next earnings release.


                         AMN Healthcare Services, Inc.
                  Condensed Consolidated Statements of Operations
                  (dollars in thousands, except per share amounts)
                                   (unaudited)

                                                    Three Months Ended
                                                          March 31,
                                                 2009         2008    % Chg

    Revenue                                  $249,595     $293,593    (15.0%)
    Cost of revenue                           185,612      216,138    (14.1%)
                                              -------      -------
     Gross profit                              63,983       77,455    (17.4%)
                               
'/>"/>
SOURCE AMN Healthcare Services, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Quest Diagnostics to Speak at the Bank of America and Merrill Lynch 2009 Healthcare Conference
2. HMS Holdings Corp. to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
3. MedPage Today(R) Named Best Online Healthcare Publication
4. ViroPharma to Present at Two May Healthcare Conferences
5. Decho Doubles Number of Mozy Healthcare Customers
6. NuVasive to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
7. Physicians Choice Leverages InstaMeds Integrated Platform for Healthcare Payment & Clearinghouse Solutions
8. Symmetry Medical to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
9. AMN Healthcare Services to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference and at the Robert W. Baird 2009 Growth Stock Conference
10. South Africa not Gaining the Full Benefit of PPPs in the Healthcare Sector, Says Frost & Sullivan
11. Ohio Selects APS Healthcare to Manage Unified Population Health Management Program for State Employees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 26, 2014 Top 10 Best SEO ... the world. The site has recently compared many hosting ... HostMonster are among the most reliable Linux web hosting ... Top 10 Best SEO Hosting says, “The hosting suppliers ... companies who outperform their competitors on hosting features, uptime ...
(Date:10/25/2014)... Triton Algae Innovations, ... Dr. Xun Wang has joined the firm as ... Triton has developed a patented synthetic biology platform for ... Dr. Wang, the platform uses algae to produce novel ... “Algae are unique because they can produce compounds that ...
(Date:10/25/2014)... New York (PRWEB) October 25, 2014 ... http://www.thexareltolawsuit.com/ ) will be addressed in December, when the ... next hearing session. According to a Hearing Session Order ... on the matter will be heard on December 4, ... begin at 9:30 a.m. (In Re: Xarelto Products Liability ...
(Date:10/25/2014)... (HealthDay News) -- Arriving home safe and sound is one ... end, be sure that costumes and goody bags have reflective ... an emergency medicine doctor at Meadowlands Hospital Medical Center in ... and costumes should be flame-resistant, Davis said. He offers ... makeup, test it on a small area of skin first ...
(Date:10/25/2014)... 2014 Background: , In 1998 Bob ... is a pioneer in the field of establishing recovery community ... treatment system and when he retired, he set out to ... public service. , 1. Where are the ... them? , 2. Can the recovery community be organized ...
Breaking Medicine News(10 mins):Health News:Top 10 Best SEO Hosting Announces That GreenGeeks.com And HostMonster Are Among The Most Reliable Linux Web Hosting Companies In 2014 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 3Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 3Health News:Tips for Safe Trick-or-Treating 2Health News:CCAR Accepting Nominations for the Bob Savage Recovery Advocate of the Year Award 2
... is unfair in dealing with people suffering from cancer. Patients ... pay higher premiums even when they can prove they are ... found that 90 percent of cancer sufferers were being denied ... cancer patients, but anyone with a pre-existing condition is treated ...
... mushrooms along with a variety of other vegetables could ... damage// , the common pathway for cancer, ageing and ... researcher, measured antioxidant capacity in several kinds of mushrooms, ... of which is called the crimini mushroom, or, when ...
... will soon become the first province in Canada to ... of heart failure//. ,The provincial agency in ... in guidelines that allowed accepting donation after cardio-circulatory death ... hundreds. ,This move to permit donations after ...
... rate of transplant surgeries, doctors are rethinking on the ... Committee (AHEC) is deliberating //over the permission for medical ... and on the ventilator, with a motive to remove ... addresses the issue of removal of organs from the ...
... scorpion venom protein showed possibilities of treating brain ... Cambridge have developed a radioactive version of a ... named TM-601, as a safer and different way ... ,Responding to this urgent problem, scientists at ...
... in London created a lot of commotion which led to the ... curable disease and is characterized by cough, phlegm, weight loss, fatigue ... many years. Elizabeth Garrett Anderson and Obstetric Hospital sent letters to ... Hospital. ,Though the health worker was diagnosed to have ...
Cached Medicine News:Health News:Ontario Addresses Shortage of Transplant Organs 2Health News:Brain Cancer Could be Safely Treated with Radioactive Scorpion Venom 2
(Date:10/22/2014)...  Quest Diagnostics (NYSE: DGX ), the ... that its Board of Directors has elected Jeffrey M. ... 1, 2014. Including Dr. Leiden, the Board has 11 ... and CEO of Vertex Pharmaceuticals.   Dr. Leiden has ... in the pharmaceutical and biotechnology industries as well as ...
(Date:10/22/2014)... RPh, of Vernak Farms Pharmacy in Skaneateles, ... Roentsch Scholarship by the Professional Compounding Centers of America ... during PCCA,s International Seminar, held October 8-10, ... pharmacist and PCCA member who embodies the innovative and ... pharmacist in the compounding community. George ...
(Date:10/22/2014)... VERNE, Calif. , Oct. 22, 2014 /PRNewswire/ ... readiness products, has developed APLS ® Body ... that minimizes the spread of bacteria and virus ... APLS Body Guard Bio features a rugged, ... finished edges that create a leak-proof inner chamber ...
Breaking Medicine Technology:Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 2Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 3PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2
... , , , ... ) today announced that in a large, randomized, double-blind, placebo-controlled, Phase ... dialysis), anemia and type-2 diabetes (the T rial to ... T herapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) ...
... , , RIDGEFIELD, Conn., Aug. ... of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran)(1) study will ... in Barcelona on Sunday, Aug. 30. The primary objective ... the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the ...
Cached Medicine Technology:Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 2Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 3Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 4Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 6Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 7Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 8Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 2Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 3Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 4Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 5Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 6Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress 7